Drug Information

General Information
Drug ID
DR00494
Drug Name
Estrone
Synonyms
(13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one; (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one;1,3,5(10)-Estratrien-3-ol-17-one; 1,3,5(10)-Oestratrien-3-ol-17-one; 3-Hydroxy-1,3,5(10)-estratrien-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; 3-Hydroxy-17-keto-oestra-1,3,5-triene; 3-Hydroxy-oestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-trien-17-one; 3-Hydroxyestra-1,3,5(10)-triene-17-one; 3-hydroxy-estra-1,3,5(10)-trien-17-one; Aquacrine; Crinovaryl; Cristallovar; Crystogen; Delta-1,3,5-Estratrien-3beta-ol-17-one; Delta-1,3,5-Oestratrien-3beta-ol-17-one; Delta-1,3,5-estratrien-3-beta-ol-17-one; Delta-1,3,5-oestratrien-3-beta-ol-17-one; Destrone; Disynformon; E 9750; E(sub 1); E0026; Endofolliculina; Esterone; Estrin; Estrogenic Substance; Estrol; Estron; Estrona; Estrona [INN-Spanish]; Estrona [Spanish]; Estrone (E1); Estrone (JAN/USP/INN); Estrone (TN); Estrone [USAN:INN]; Estrone, (+-)-Isomer; Estrone, (8 alpha)-Isomer; Estrone, (9 beta)-Isomer; Estrone-A; Estronum; Estronum [INN-Latin]; Estrovarin; Estrugenone; Estrusol; Fem-O-Gen; Femestrone inj.; Femestrone injection; Femidyn; Fermidyn; Folikrin; Folipex; Folisan; Follestrine; Follestrol; Follicular hormone; Folliculin; Folliculine; Folliculine benzoate; Follicunodis; Glandubolin; Hauck Brand of Estrone; Hiestrone; Hormestrin; Hormofollin; Hormovarine; Hyrex Brand of Estrone; Kestrone; Ketodestrin; Ketohydroxy-Estratriene; Ketohydroxyestrin; Ketohydroxyoestrin; Ketophydroxyestrin; Kolpon; Menagen; Menformon; Menformon A; Mestronaq; NATURAL ESTROGENIC SUBSTANCE-ESTRONE; OESTRONE; Oestrin; Oestroform;Oestronum; Oestrone [Steroidal oestrogens]; Oestrone, Estrone; Oestroperos; Ovex (tablets); Ovifollin; Penncap M; Perlatan; Solliculin; Theelin; Thelestrin; Thelykinin; Thynestron; Tokokin; Unden; Unden (pharmaceutical); Unden (pharmaceutical) (VAN); Unigen; Vortech Brand of Estrone; Wehgen; Wynestron; WynestronPencap M;CMC_13458; [2,4,6,7-3H]-E1
Drug Type
Small molecular drug
Indication Postmenopausal disorder [ICD11: GA30.Z] Approved [1]
Therapeutic Class
Antimenopausal Agents
Structure
3D MOL 2D MOL
Formula
C18H22O2
Canonical SMILES
CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O
InChI
InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1
InChIKey
DNXHEGUUPJUMQT-CBZIJGRNSA-N
CAS Number
CAS 53-16-7
Pharmaceutical Properties Molecular Weight 270.4 Topological Polar Surface Area 37.3
Heavy Atom Count 20 Rotatable Bond Count 0
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2
XLogP
3.1
PubChem CID
5870
PubChem SID
11466942 , 11468062 , 11486713 , 14714953 , 14750534 , 14774967 , 17405076 , 24278427 , 24715020 , 24870303 , 24894399 , 26512283 , 26751561 , 26751562 , 2687 , 29224898 , 3133155 , 3751 , 46505916 , 46517467 , 47213246 , 47275539 , 47424227 , 47646545 , 47646546 , 47646547 , 47720600 , 47943749 , 48094530 , 48243347 , 48318399 , 48421873 , 49684201 , 49699003 , 49965933 , 50104169 , 50104170 , 50124146 , 50124147 , 50124148 , 50967133 , 53777619 , 53787846 , 613807 , 7847135 , 7979191 , 8144215 , 8153628 , 841396 , 855919
ChEBI ID
ChEBI:17263
TTD Drug ID
D00ZFP
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Estrone was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.